Study of apatinib in patients with locally advanced unresectable or metastatic hepatocellular carcinoma
Latest Information Update: 14 Nov 2022
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 14 Nov 2022 New trial record
- 31 Oct 2022 Results published in the BMC Gastroenterology